Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002207847 | SCV002373684 | likely benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002207847 | SCV002513110 | uncertain significance | not provided | 2023-06-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV003250453 | SCV003963659 | uncertain significance | Inborn genetic diseases | 2023-04-04 | criteria provided, single submitter | clinical testing | The c.1735C>A (p.P579T) alteration is located in exon 30 (coding exon 30) of the COL9A3 gene. This alteration results from a C to A substitution at nucleotide position 1735, causing the proline (P) at amino acid position 579 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |